Skip to main content
. 2017 Apr 24;8(27):44171–44185. doi: 10.18632/oncotarget.17396

Table 3. IC50 value to oxaliplatin in different siRNA treatment groups after knocking-down PKM2/GLS1 expression in the THC8307/Oxa cell line.

Treatment groups IC50 (μg/mL)
THC8307/Oxa 25.37
THC8307/Oxa-NCsiRNA 27.09
THC8307/Oxa-siPKM2 24.95
THC8307/Oxa-siGLS1 3.69
THC8307/Oxa-siPKM2 plus siGLS1 2.52